ClotTriever Outcomes (CLOUT) Registry
Completed · NCT03575364
Conditions: Deep Vein Thrombosis Leg, DVT, Chronic DVT of Lower Extremity, Acute DVT of Lower Extremity
At a glance
- Research payments reported, 2025
- $3,893
- U.S. investigators named
- 1
- Sites paid
- 0
- Planned or actual enrollment
- 499
About the trial
- Sponsor
- Inari Medical
- Tested
- ClotTriever (device)
- Dates
- Started 2018-09-01; completion 2024-07-02
- Results posted
- Yes
Evaluate real world patient outcomes after treatment of acute, subacute, and chronic proximal lower extremity deep vein thrombosis (DVT) with the ClotTriever Thrombectomy System.
From ClinicalTrials.gov, last updated 2025-08-26. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Stryker Corporation reported $3,893 in research payments for this study in 2025 (2 payments).
Products named: Ct Thrombectomy System Kit
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- $3,893
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.